Compound kushen injection relieves tumor-associated macrophage-mediated immunosuppression through TNFR1 and sensitizes hepatocellular carcinoma to sorafenib

Yang Yang(Chengdu University of Traditional Chinese Medicine), Hui Wang(Beijing University of Chinese Medicine), Rongli You(Shanxi Zhendong Pharmaceutical (China)), Lin Qiu(Third Affiliated Hospital of Zhengzhou University), Qian Ba(Shanghai University of Traditional Chinese Medicine), Mayu Sun(Shanghai Jiao Tong University), Xiaoguang Li(Beijing University of Technology), Wei Wang(Capital Medical University), Feng Wang(Shanghai Institute of Nutrition and Health), Jingquan Li, Wenbo Yao(Jilin University), Chenghua Yang(Second Military Medical University), Zhihu Gao(Shanghai Institute of Nutrition and Health)
Journal for ImmunoTherapy of Cancer
March 1, 2020
Cited by 153


Related Papers